Sef is a negative regulator of fiber cell differentiation in the ocular lens

Peter Newitt1, Jessica Boros, Bhavani P Madakashira

  • 1Save Sight Institute, University of Sydney, NSW, Australia.

Insights

Sef, a growth factor antagonist, was overexpressed in mouse lenses, causing impaired eye development and microphthalmia. This suggests Sef negatively regulates fibroblast growth factor signaling, crucial for lens development.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Ophthalmology

Background:

  • Growth factor signaling via receptor tyrosine kinases (RTKs) requires tight regulation during development.
  • Fibroblast Growth Factors (FGFs) are critical for vertebrate ocular lens development, influencing cell proliferation, differentiation, and patterning.
  • Sef (similar expression to fgfs) is an antagonist of FGF signaling, identified in lens epithelial cells.

Purpose of the Study:

  • To investigate the role of Sef in regulating lens cell behavior and eye development.
  • To determine if Sef acts as a negative regulator of FGF signaling in the ocular lens.
  • To explore the potential of opposing growth factor and antagonist gradients in tissue patterning.

Main Methods:

  • Utilized transgenic mouse models to overexpress Sef specifically in the lens.
  • Observed and analyzed lens and eye development in Sef-overexpressing mice.
  • Assessed lens cell elongation, differentiation, and apoptosis.

Main Results:

  • Overexpression of Sef in the lens led to impaired lens and eye development, resulting in microphthalmia.
  • Sef inhibited primary lens fiber cell elongation and differentiation.
  • Increased apoptosis was observed, indicating a blockage in FGF receptor (FGFR)-mediated signaling.

Conclusions:

  • Sef acts as a significant negative regulator of FGF signaling during lens morphogenesis.
  • The lens serves as a model to understand how opposing gradients of growth factors and antagonists establish tissue patterns.
  • Sef plays a crucial role in maintaining normal eye development by modulating FGF signaling pathways.